Pegilodecakin with nivolumab (nivo) or pembrolizumab (pembro) in patients (pts) with metastatic renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Tannir, N. M.; Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Wong, D. J. L.; Korn, M.; Aljumaily, R.; Autio, K. A.; Pant, S.; Bauer, T. M.; Drakaki, A.; Daver, N. G.; Hung, A.; Van Vlasselaer, P.; Leveque, J.; Oft, M. |
| Abstract Title: | Pegilodecakin with nivolumab (nivo) or pembrolizumab (pembro) in patients (pts) with metastatic renal cell carcinoma (RCC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 243s |
| Language: | English |
| ACCESSION: | WOS:000442916002036 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4509 -- Source: Wos |
